Shopping Cart
- Remove All
- Your shopping cart is currently empty
Hemopressin(rat) TFA, a nonapeptide originating from the α1-chain of hemoglobin, was first isolated from rat brain homogenates. It acts as an orally active, selective, and inverse agonist of the CB1 cannabinoid receptors and demonstrates antinociceptive effects in models of inflammatory pain [1] [2].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | Inquiry | 8-10 weeks | |
50 mg | Inquiry | 8-10 weeks |
Description | Hemopressin(rat) TFA, a nonapeptide originating from the α1-chain of hemoglobin, was first isolated from rat brain homogenates. It acts as an orally active, selective, and inverse agonist of the CB1 cannabinoid receptors and demonstrates antinociceptive effects in models of inflammatory pain [1] [2]. |
In vivo | Hemopressin(rat) TFA induces hypotension in anesthetized rats, undergoing metabolism by endopeptidase 24.15 (EP24.15), neurolysin (EP24.16), and angiotensin-converting enzyme (ACE) [1]. When administered orally, it mitigates mechanical hyperalgesia in CCI-rats for up to 6 hours. Additionally, treatment with Hemopressin(rat) TFA reduces Egr-1 immunoreactivity (Egr-1Ir) in the spinal cord's superficial dorsal horn of CCI rats [2]. |
Molecular Weight | 1202.28 |
Formula | C55H78F3N13O14 |
Cas No. | 1431329-47-3 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.